Mansukh Mandaviya Packs a Punch in COVID Vaccination
New Delhi: Mansukh Mandaviya needed a Godspeed because he has been handed Health Ministry in testing times. The speeding up of vaccination drive underlines he is packing a punch. September…
A RESILIENT INDIA AT 75: Dr Azad Moopen
Dubai/ India: Over the years India has emerged as an economic superpower and a force to reckon with, strengthened by its 1.3 billion people and shaped by its visionary leadership…
Bharat Biotech begins direct supply of COVAXIN to 14 states
Bharat Biotech has commenced direct supply of its C-19 vaccine ‘COVAXIN’ to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company’s Joint Managing Director…
Jab ready Sir Ganga Ram Hospital
New Delhi: True to its tradition, Sir Ganga Ram Hospital is always battle ready. Mass Covid Vaccination is no different. The hospital is poised for Covishield vaccination from tomorrow. With…
Bharat Biotech Dispatches Covaxin Supplies To 11 Cities
HYDERABAD : Vaccine maker Bharat Biotech has started supplies of Covaxin, the COVID-19 vaccine it has developed in collaboration with the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV). The…
Bharat Biotech Chief Takes On Serum Institute In Vaccine War
Mumbai : A vaccine war has surfaced as India prepares for a massive inoculation drive to prevent the spread of coronavirus, which has killed more than 150,000 in the country. A…
Submitted All Data As Per Guidelines, Says Bharat Biotech
HYDERABAD : Amid concerns over the Indian drug regulator granting emergency use authorisation (EUA) approval to the indigenous Covid-19 vaccine candidate Covaxin even as its Phase 3 trials are underway,…
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
New Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here on Thursday with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute,…
Bharat Biotech to launch Covaxin in Q2 2021
New Delhi: Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company…
Bharat Biotech’s COVAXIN gets DCGI approval for Phase I & II Human Clinical Trials
COVAXIN has been successfully developed by Bharat Biotech, a vaccine for COVID-19 by collaborating with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2…
